Emerging functions of the EGFR in cancer

Publisher： John Wiley & Sons Inc

E-ISSN： 1878-0261|12|1|3-20

ISSN： 1574-7891

Source： Molecular Oncology, Vol.12, Iss.1, 2018-01, pp. : 3-20

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

The Emerging Role of NRAS Mutations in Colorectal Cancer Patients Selected for Anti-EGFR Therapies

By  

Reviews on Recent Clinical Trials, Vol. 9, Iss. 1, 2014-03 ,pp. : 8-12

Bentham Science Publishers

Access to resources Recommend Favorite

EGFR Inhibitors in the Treatment of Lung Cancer

By  

Oncology Research and Treatment, Vol. 30, Iss. 10, 2007-09 ,pp. : 476-476

Karger

Access to resources Recommend Favorite

Clinical Predictors of Response to EGFR Tyrosine Kinase Inhibitors in Patients with EGFR-Mutant Non-Small Cell Lung Cancer

By  

Oncology, Vol. 86, Iss. 2, 2014-01 ,pp. : 86-93

Karger

Access to resources Recommend Favorite

Impact of EGFR-Tyrosine Kinase Inhibitors on Postoperative Recurrent Non-Small-Cell Lung Cancer Harboring EGFR Mutations

By  

Oncology Research and Treatment, Vol. 40, Iss. 1-2, 2017-01 ,pp. : 7-13

Karger

Access to resources Recommend Favorite

The emerging functions of regulatory RNA species in skin biology

By  

EXPERIMENTAL DERMATOLOGY (ELECTRONIC), Vol. 24, Iss. 11, 2015-11 ,pp. : 827-828

John Wiley & Sons Inc

Access to resources Recommend Favorite